Add Row
Add Element
Parallel Health World News Logo
update

Parallel Health World

cropper
update
Add Element
  • Home
  • Categories
    • EcoHealth Trends
    • Healing Naturally
    • Age-Defying Diets
    • Supplement Savvy
    • Mind-Body Synergy
    • Finance and Health
    • Biolimitless
    • Tech Hacks
    • Health & Medicine
    • Political
    • BioBuzz
    • Holistic Rehabilitation Techniques
    • Practitioner Insights
    • AI In Healthcare
  • Featured Business Profiles
January 11.2026
3 Minutes Read

BDMS Achieves Breakthrough ICHOM Level 2 Accreditation: A New Era for Patient-Centered Care

Group of professionals discussing ICHOM Level 2 Accreditation.

BDMS Sets a New Standard with ICHOM Level 2 Accreditation

Bangkok Dusit Medical Services (BDMS) recently celebrated a groundbreaking achievement by becoming the first organization globally to attain Level 2 certification under the International Consortium for Health Outcomes Measurement (ICHOM) Accreditation Program. This significant milestone was awarded after rigorous independent assessments of its clinical pathways in Stroke, Coronary Artery Disease, and Nonmetastatic Breast Cancer at the Bangkok Hospital Pattaya and the Bangkok Cancer Hospital Wattanosoth.

What Does Level 2 Accreditation Mean?

According to ICHOM, Level 2 certification signifies that an organization has gone beyond merely implementing outcomes measurement—it demonstrates the capability to produce independently verified, high-quality data that is actively utilized in clinical practices. This achievement reflects BDMS’s persistent dedication to not only capturing patient outcomes but also translating them into actionable improvements in care. The certification shows a commitment to patient-centered healthcare, underscoring the importance of measuring health outcomes that truly matter to patients.

A Focus on Patient Outcomes

The emphasis on patient outcomes is a fundamental shift in healthcare delivery, moving away from a strictly procedure-based model to one that prioritizes what patients actually experience and desire from their care. BDMS's achievement highlights an essential transformation occurring across the global healthcare landscape. As healthcare providers increasingly adopt value-based care, BDMS stands as a beacon of success, demonstrating that patient-reported outcomes (PROMs) can lead to improved care quality.

Global Implications and Future Trends

BDMS’s recognition has larger ramifications for healthcare systems worldwide. The ICHOM framework is being applied not just in Asian contexts but across various regions, as organizations seek to adopt a standardized approach to measuring health outcomes. This can potentially lead to enhanced comparisons between different healthcare services internationally, fostering a culture of transparency and continuous improvement. As more organizations follow BDMS's lead, the healthcare landscape will broaden its focus toward accountability and patient-driven care.

Enhancing Healthcare Quality

As the world becomes accustomed to the idea of health care being driven by patient needs, it creates an environment where continuous learning and adaptability become integral. BDMS's Level 2 accreditation has paved the way for other healthcare organizations to scrutinize their practices critically. They can implement robust frameworks for measuring how well they serve their patients—ultimately transforming the quality of care delivered.

Conclusion: The Importance of Patient-Centered Care

The journey towards ICHOM Level 2 Accreditation is a monumental achievement that not only enhances BDMS’s reputation but also signals critical changes in approach within the healthcare sector. Patient-centered care is becoming a vital part of reputable healthcare delivery systems, encouraging organizations to embed patient perspectives into the heart of their operations.

Through the application of standardized outcome measurement, organizations can reassure patients that their voices are not just heard, but acted upon, leading to improved health outcomes and increased satisfaction. BDMS’s accomplishment serves as an enlightening example for healthcare providers across the globe, reinforcing the idea that accountability and patient care go hand-in-hand, leading to a healthier future for all.

Practitioner Insights

1 Views

0 Comments

Write A Comment

*
*
Related Posts All Posts
01.01.2026

Thailand's BDMS Wattanosoth Joins Revolutionary Breast Cancer Care Initiative

Update Thailand's Groundbreaking Contribution to Global Breast Cancer Care In a significant move for cancer care in Southeast Asia, BDMS Wattanosoth Cancer Hospital has joined the inaugural International Consortium for Health Outcomes Measurement (ICHOM) Breast Cancer Learning Collaborative. This collaboration unites prominent cancer care institutions from around the world, bringing Thailand to the forefront of a global effort that emphasizes patient-centered outcomes in breast cancer treatment. Collaborative Efforts to Improve Patient Care Wattanosoth's participation as the first Thai hospital in this initiative is more than just symbolic; it underscores a commitment to enhancing cancer care through data sharing and collaborative learning. By contributing real-world outcomes data, the hospital will work hand-in-hand with counterparts from Australia, Belgium, Israel, the Netherlands, and Brazil, focusing on establishing best practices that can elevate the quality of life for breast cancer patients. Dr. Satit Srimontayamas, a prominent breast surgeon and the Director at Wattanosoth, emphasized that establishing clear and effective clinical pathways through collaboration will increase survival rates and improve patient experiences. This aligns with emerging evidence that comprehensive care strategies significantly impact patient outcomes. The Holistic Approach to Breast Cancer Care In line with this initiative, Wattanosoth’s philosophy pivots around a holistic model of care encapsulated in the concept of “Care Beyond Cure.” As highlighted in a recent report by the Bangkok Post, patient-centered experiences are paramount, tackled through combined efforts with BDMS Wellness Clinic to deliver customized post-treatment support. The focus is not just on treatment but also on the broader well-being of patients, ensuring they have access to emotional and social support long after their treatment ends. Impact on Patient Outcomes Emerging research shows that cancer treatment is not solely about eradicating the disease. Psychosocial factors like emotional support, dietary needs, and rehabilitation significantly influence recovery. The collaboration with ICHOM aims to integrate these concepts into standardized care pathways that others can replicate globally. According to Prof. Dr. Thiravud Khuhaprema, Director of Wattanosoth, understanding the value of lifestyle and environmental factors provides a more comprehensive perspective on patient health. Innovations in treatment, such as minimally invasive surgeries and personalized therapies guided by genetic profiling, are crucial for tailoring effective care. Future Predictions and Opportunities As this initiative unfolds, it paves the way for a paradigm shift in breast cancer care, not just in Thailand but worldwide. Expect future collaborations to foster advanced strategies integrating technological innovations such as telemedicine and AI into treatment protocols. This movement towards value-based care will likely redefine how healthcare systems assess success, focusing on patient-reported outcomes and life quality instead of just survival rates. Conclusion: Taking Action for Change With the global cancer burden ever-increasing, it’s essential for healthcare systems to adopt collaborative frameworks like ICHOM’s initiatives. Those interested in further understanding how they can contribute or engage in improving breast cancer care are encouraged to visit ICHOM's website to learn more about ongoing projects and how their involvement can effect real change in patient care worldwide.

12.31.2025

Unlocking Value-Based Care: Tawuniya's Impact on Patient-Reported Outcomes in Saudi Arabia

Update Revolutionizing Patient Care Through Value-Based ModelsThe recent study by Tawuniya highlights a pivotal development in Saudi Arabia’s healthcare landscape, illustrating an embrace of value-based care through patient-reported outcomes (PROs). This study signifies not merely a shift in how healthcare is delivered but emphasizes the importance of understanding patients' perspectives on their treatment outcomes.The data gathered from 97 patients, treated with the ICHOM Low Back Pain Set, showcased significant improvements in pain management and quality of life metrics over a six-month follow-up period. Such findings echo the sentiments shared in Oliver Wyman's article on the pathway to value-based healthcare in Saudi Arabia, which underscores the necessity of aligning healthcare expenditures with patient outcomes rather than service volume.Importance of Patient-Reported Outcomes (PROs)PATIENT-REPORTED OUTCOMES represent firsthand accounts of patients regarding their health status, without any clinician's interpretation. Integrating PROs within the healthcare framework not only improves patient engagement but ensures that treatments are aligned with the actual needs and expectations of patients. This is particularly relevant in Saudi Arabia, where healthcare reforms are aiming to enhance patient-centeredness as part of the Vision 2030 initiative.Insights From A Broader PerspectiveIt's crucial to acknowledge that despite the positive findings from Tawuniya's study, challenges remain in the incorporation of PROs in broader healthcare practices. As highlighted in the Saudi Medical Journal's examination of clinical trials in Saudi Arabia, around 40% of registered interventional trials reported PRO usage. However, barriers such as the predominance of non-industry-sponsored studies affecting PRO utilization rates persist. Numerous trials miss an opportunity to harness patient insights for better decision-making.Moreover, a collaborative approach amongst healthcare stakeholders is essential, as pointed out in Oliver Wyman's insights on institutional collaborations. By breaking down barriers between payers, providers, and patients, Saudi Arabia can foster an environment where data-backed decisions improve treatment pathways and empower practitioners.Challenges and Future DirectionsTransitioning to a more value-based healthcare model will require overcoming existing silos within the system. Shared governance and dedicated condition-level outcome sets as prescribed in multiple penalties can create the necessary framework for achieving alignment in objectives across all stakeholders. As the current study results demonstrate, metrics driven by patient outcomes prove that resources can be allocated more efficiently if robust systems for reporting and utilizing PROs are established.As the Kingdom advances towards its Vision 2030 goals, this transformation can potentially herald a new era in healthcare, prioritizing outcomes that genuinely matter to patients.Looking Ahead: Stakeholders' Roles in Advancing PRO UseThe continuous evolution of healthcare policies and practices in Saudi Arabia necessitates an ongoing dialogue among stakeholders regarding the adaptation and adoption of new frameworks centered around value-based care. To enhance the overall patient experience, initiatives aimed at integrating PROs need to be paired with actionable insights derived from collected data, which can, in turn, define future treatment protocols.Ultimately, the evidence supporting the beneficial impacts of PROs is compelling. Enhanced communication and transparency can foster an enriching environment where patient needs are prioritized, thus driving better health outcomes that are efficient, sustainable, and cost-effective.The full study results and accompanying visual poster shed light on the practical applications of these findings, encouraging healthcare professionals and policymakers to take heed of patient voices as integral components of healthcare delivery.

12.31.2025

Understanding the ICHOM Multiple Sclerosis Set: A Game Changer in Patient-Centered Care

Update ICHOM Launches Innovative MS Outcome MeasuresThe International Consortium for Health Outcome Measurement (ICHOM) has introduced a new set of Patient-Centered Outcome Measures (PCOM) for Multiple Sclerosis (MS), aimed at enhancing the quality of care for adults 18 and older living with this complex condition. By focusing on consistent, standardized assessments, the MS Set is expected to transform how healthcare professionals measure and respond to patient needs.Expert Collaboration Shapes the New SetDeveloped in partnership with the St. Antonius Hospital in the Netherlands and guided by leading neurologists such as Dr. Stephan Frequin and Professor Dr. Paul van der Nat, the MS Set emerged from extensive collaborative research. Seventeen clinical and methodological experts from eight nations contributed to its creation, alongside input from patient focus groups made up of 30 individuals living with MS. This comprehensive approach underscores the importance of aligning scientific evidence with real-world patient priorities, incorporating a structured literature review and a RAND-modified Delphi methodology to establish consensus.Transformative Patient-Centric DesignThe MS Set is designed to reshape patient care through its emphasis on practical usability. Kirsten Daniels, MSc, the project lead, expressed hope that this new resource will inspire healthcare professionals around the globe to adopt these outcome measures. The integration of patient voice into this development not only grounds the content in the realities faced by those with MS but also catalyzes a more responsive healthcare system.What this Means for Healthcare ProvidersThe release of the Multiple Sclerosis Set marks a significant advancement in value-based healthcare, emphasizing outcomes that truly matter to patients. This shift encourages healthcare providers to move away from traditional metrics, focusing instead on indicators that factor in patient experiences and satisfaction. Such a transition is critical in creating a healthcare framework that prioritizes meaningful improvement in patient quality of life.Implications for MS PatientsThe impact of these newly standardized measures on patients living with MS could be substantial. By tailoring care processes to their specific needs and priorities, healthcare practitioners can enhance engagement and accountability in patient care. As healthcare evolves, it is expected that patients will have better access to personalized treatment plans based on their unique experiences with the disease.The Future of MS Outcomes MeasurementWith the ICHOM MS Set now finalized and accessible, the focus turns to its implementation. Clinical settings that adopt these measures will likely witness improved patient outcomes and satisfaction, setting a new standard in the treatment of MS. The ongoing evaluation of how effectively these measures translate into practice will be essential in establishing their long-term benefits.Embracing Change in Healthcare DeliveryThe launch of the ICHOM MS Set signifies a pivotal moment in healthcare delivery, particularly for conditions like MS that require nuanced understanding and care. As more healthcare systems begin to prioritize patient-centered metrics, it is hoped that these outcomes will steer a more compassionate and efficient care pathway for those affected by this chronic illness. The synergy of scientific evidence and lived experience in care decisions is now more critical than ever, laying a foundation for a healthier future for MS patients worldwide.

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*